Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of a Digital Therapeutic and Connected Devices to Support Insulin Titration

NCT03908762 is registered in ClinicalTrials.gov with Amalgam Rx, Inc. as lead sponsor.

NCT NCT03908762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03908762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of a Digital Therapeutic and Connected Devices to Support Insulin Titration
Lead sponsor
Amalgam Rx, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2019
Completion date
March 31, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, diabetic complication